Frequency News and Research

RSS
Research findings provide insight into safety of central line uses outside hospital

Research findings provide insight into safety of central line uses outside hospital

Study finds that higher-frequency electric current stimulation of the spinal cord reduces pain faster

Study finds that higher-frequency electric current stimulation of the spinal cord reduces pain faster

New data questions surgical options for treating kidney cancer

New data questions surgical options for treating kidney cancer

Study: Heart disease emerges as number one killer among Indians

Study: Heart disease emerges as number one killer among Indians

JACS reports study on LINX Reflux Management System for GERD treatment

JACS reports study on LINX Reflux Management System for GERD treatment

Mortality rates declining among dialysis patients despite rise in coronary artery disease, study finds

Mortality rates declining among dialysis patients despite rise in coronary artery disease, study finds

Academic hospitals have higher mammography recall rates than community radiology centers

Academic hospitals have higher mammography recall rates than community radiology centers

Diet soda: No better than regular soda

Diet soda: No better than regular soda

Research reveals how brains pick out important sounds from noisy world

Research reveals how brains pick out important sounds from noisy world

Bruker introduces AVANCE-IVDr platform for NMR clinical research and screening

Bruker introduces AVANCE-IVDr platform for NMR clinical research and screening

Overall risk of injury death is lower in urban areas compared to outside of cities

Overall risk of injury death is lower in urban areas compared to outside of cities

Array BioPharma announces positive results from ARRY-502 Phase 2 trial for allergic asthma

Array BioPharma announces positive results from ARRY-502 Phase 2 trial for allergic asthma

p53 and cancer research: an interview with Professor Sir David Lane, Scientific Director of the Ludwig Institute for Cancer Research

p53 and cancer research: an interview with Professor Sir David Lane, Scientific Director of the Ludwig Institute for Cancer Research

High arsenic levels in rice pose potential threat to human health: Study

High arsenic levels in rice pose potential threat to human health: Study

BioCryst completes BCX4161 Phase 1 clinical trial for treatment of hereditary angioedema

BioCryst completes BCX4161 Phase 1 clinical trial for treatment of hereditary angioedema

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

Vegetation may not protect people from ozone pollution, says new research

Vegetation may not protect people from ozone pollution, says new research

EU-funded project examines dietary habits in people with inadequate nutrition

EU-funded project examines dietary habits in people with inadequate nutrition

NKX2-8 mutation in dogs may be a risk factor for human neural tube defects, say researchers

NKX2-8 mutation in dogs may be a risk factor for human neural tube defects, say researchers

Risk Weighted Cumulative Exposure can measure cumulative risk of concussion in football players

Risk Weighted Cumulative Exposure can measure cumulative risk of concussion in football players

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.